Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker) , alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids

Ocón, J.; Piña, C.; Castellet, R.; Vila, R.; del Río, G.; Arnau, C.

Medicina Clinica 85(2): 53-57

1985


ISSN/ISBN: 0025-7753
PMID: 3894828
Document Number: 256392
Risk factors were measured to observe short term changes with penbutolol (P), a new .beta.-blocker (Hoe 893 d). No changes were seen on Ccr and aldosterone followed the expected changes when treated with .beta.-blockers and diuretics. There was no correlation found between control PRA and hypotensive effect when treated with the .beta.-blocker, (r = 0.015), nor with the diuretic (r = 0.17).

Document emailed within 1 workday
Secure & encrypted payments